AZO
43
-2
AXP
69
2
FTI
78
9
CRM
59
9
BRK.B
45
3
V
56
-8
BAC
47
8
MRK
50
-3
FRT
38
-3
TEL
66
3
ISRG
71
5
HD
54
4
ADBE
56
5
XRAY
34
2
LUV
33
-3
TROW
39
4
ITW
64
2
MAT
54
3
DTE
54
-2
BK
74
2
AZO
43
-2
AXP
69
2
FTI
78
9
CRM
59
9
BRK.B
45
3
V
56
-8
BAC
47
8
MRK
50
-3
FRT
38
-3
TEL
66
3
ISRG
71
5
HD
54
4
ADBE
56
5
XRAY
34
2
LUV
33
-3
TROW
39
4
ITW
64
2
MAT
54
3
DTE
54
-2
BK
74
2
Financhill
Back

Ovid Therapeutics Quote, Financials, Valuation and Earnings

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16

OVID
Ovid Therapeutics

Last Price:
1.17
Seasonality Move:
-0.74%

7 Day Trial

ALL ACCESS PASS

$ 7

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Ovid Therapeutics Price Quote

$1.17

Ovid Therapeutics Key Stats

Sell
16
Ovid Therapeutics (OVID) is a Sell
Day range:
$1.06 - $1.17
52-week range:
$0.68 - $4.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
145.97
P/B ratio:
0.93%
Volume:
92.3K
Avg. volume:
211.8K
1-year change:
-69.61%
Market cap:
$83M
Revenue:
$391.7K
EPS:
$-0.43

How Much Does Ovid Therapeutics Make?

Is Ovid Therapeutics Growing As A Company?

  • What Is Ovid Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.25%
  • What Is Ovid Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ovid Therapeutics Stock Price Performance

What Is Ovid Therapeutics 52-Week High & Low?

Ovid Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ovid Therapeutics?

  • How Much Debt Does Ovid Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Ovid Therapeutics Have?
    Cash and short term investments quarterly total is $77M
  • What Is Ovid Therapeutics’s Book Value Per Share?
    Book value per share is 1.25

Is Ovid Therapeutics Cash Flow Positive?

  • What Is OVID Cash Flow From Operations?
    Cash flow from operations (TTM) is -$52.9M
  • What Is Ovid Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $30.8M
  • What Is Ovid Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$19.9M

Ovid Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    OVID return on invested capital is -31.85%
  • What Is Ovid Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -22.71%
  • What Is OVID Return On Equity?
    ROE is a measure of profitability and is -31.85%

Ovid Therapeutics Earnings Date & Stock Price

Ovid Therapeutics Competitors

  • Who Are Ovid Therapeutics's Competitors?
    Below is a list of companies who compete with Ovid Therapeutics or are related in some way:
    • Arcutis Biotherapeutics Inc (ARQT)
    • GlycoMimetics Inc (GLYC)
    • Innoviva Inc (INVA)
    • Marinus Pharmaceuticals Inc (MRNS)
    • Tonix Pharmaceuticals Holding Corp (TNXP)

Ovid Therapeutics Dividend Yield

Ovid Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 150.12%
Revenue: 125.33% 219.59%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 3.26
Upside from Last Price: 178.63%

Major Shareholders

  • How many OVID shares are owned by institutional investors?
    48.8M OVID shares are owned by institutional investors
  • How many OVID shares are owned by insiders?
    8.8M OVID shares are owned by insiders